Cipla launches quality-assured Rectal Artesunate Suppositories for severe malaria in young children
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
Browsing: Medicines for Malaria Venture
Medicines for Malaria Venture announces collaborative agreement with S Kant HEALTHCARE Ltd
Medicines for Malaria Venture (MMV) has established a new collaboration with S Kant HEALTHCARE Ltd…
300 million child-friendly antimalarial treatments supplied without profit by Novartis
Novartis announced today that it has reached a delivery milestone of 300 million paediatric antimalarial…